Whole Exome Sequencing Identified a Novel Mutation in the LOXHD1 Gene in Consanguineous Iranian Families With Hearing Loss

IF 2.5 4区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY
Journal of Clinical Laboratory Analysis Pub Date : 2026-09-23 Epub Date: 2026-08-18 DOI:10.1002/jcla.70327
Solmaz Hassani Fard Katiraei, Milad Gholami, Mohsen Soosanabadi, Mona Entezam, Seyed Alireza Dastgheib
{"title":"Whole Exome Sequencing Identified a Novel Mutation in the LOXHD1 Gene in Consanguineous Iranian Families With Hearing Loss","authors":"Solmaz Hassani Fard Katiraei,&nbsp;Milad Gholami,&nbsp;Mohsen Soosanabadi,&nbsp;Mona Entezam,&nbsp;Seyed Alireza Dastgheib","doi":"10.1002/jcla.70327","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Hearing loss is one of the most common sensory disorders caused by genetic and environmental factors. Autosomal recessive non-syndromic hearing loss (ARNSHL) is extremely heterogeneous, with over 100 genes known to be involved. Hearing loss can result from mutations in the LOXHD1 gene, which codes a highly conserved protein known as lipoxygenase and is located at 18q21.1. Despite the association between LOXHD1 mutations and ARNSHL, there are still few documented cases.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We examined a case of non-syndromic hearing loss in an Iranian family with a history of consanguinity and several affected siblings. Next-generation sequencing (NGS) was conducted on the proband to discover causal genetic alterations. Sanger sequencing was employed to confirm the identified variation.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>A novel likely pathogenic variant in the LOXHD1 gene, c.3713dupA (p.Asp1238Glufs*10), was identified. Sanger sequencing was used to confirm that the affected family members had this frameshift mutation.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Our findings broaden the mutational range of LOXHD1 linked to ARNSHL. This unique variant enhances the comprehension of the genetic underpinnings of hearing loss and may aid in molecular diagnostics and genetic counseling for impacted families.</p>\n </section>\n </div>","PeriodicalId":15509,"journal":{"name":"Journal of Clinical Laboratory Analysis","volume":"40 18","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2026-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13487026/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Laboratory Analysis","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jcla.70327","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/18 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Hearing loss is one of the most common sensory disorders caused by genetic and environmental factors. Autosomal recessive non-syndromic hearing loss (ARNSHL) is extremely heterogeneous, with over 100 genes known to be involved. Hearing loss can result from mutations in the LOXHD1 gene, which codes a highly conserved protein known as lipoxygenase and is located at 18q21.1. Despite the association between LOXHD1 mutations and ARNSHL, there are still few documented cases.

Methods

We examined a case of non-syndromic hearing loss in an Iranian family with a history of consanguinity and several affected siblings. Next-generation sequencing (NGS) was conducted on the proband to discover causal genetic alterations. Sanger sequencing was employed to confirm the identified variation.

Results

A novel likely pathogenic variant in the LOXHD1 gene, c.3713dupA (p.Asp1238Glufs*10), was identified. Sanger sequencing was used to confirm that the affected family members had this frameshift mutation.

Conclusion

Our findings broaden the mutational range of LOXHD1 linked to ARNSHL. This unique variant enhances the comprehension of the genetic underpinnings of hearing loss and may aid in molecular diagnostics and genetic counseling for impacted families.

Abstract Image

全外显子组测序在听力损失的伊朗近亲家庭中发现了LOXHD1基因的新突变。
背景:听力损失是由遗传和环境因素引起的最常见的感觉障碍之一。常染色体隐性非综合征性听力损失(ARNSHL)是一种异质性很强的疾病,已知涉及100多个基因。听力损失可能是由LOXHD1基因突变引起的,该基因编码一种高度保守的蛋白质,称为脂氧合酶,位于18q21.1。尽管LOXHD1突变与ARNSHL之间存在关联,但仍然很少有文献记载的病例。方法:我们检查了一个伊朗家庭的非综合征性听力损失病例,该家庭有血亲史和几个患病的兄弟姐妹。对先证者进行下一代测序(NGS)以发现因果遗传改变。采用Sanger测序来确认鉴定的变异。结果:在LOXHD1基因中鉴定出一种新的可能致病变异c.3713dupA (p.Asp1238Glufs*10)。Sanger测序被用来确认受影响的家庭成员有这种移码突变。结论:我们的发现扩大了与ARNSHL相关的LOXHD1的突变范围。这种独特的变异增强了对听力损失的遗传基础的理解,并可能有助于分子诊断和受影响家庭的遗传咨询。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical Laboratory Analysis
Journal of Clinical Laboratory Analysis 医学-医学实验技术
CiteScore
5.60
自引率
7.40%
发文量
584
审稿时长
6-12 weeks
期刊介绍: Journal of Clinical Laboratory Analysis publishes original articles on newly developing modes of technology and laboratory assays, with emphasis on their application in current and future clinical laboratory testing. This includes reports from the following fields: immunochemistry and toxicology, hematology and hematopathology, immunopathology, molecular diagnostics, microbiology, genetic testing, immunohematology, and clinical chemistry.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书